Adipokines, Insulin Resistance, and Coronary Artery Calcification

Journal of the American College of Cardiology

Volumn 52, Issue 3, 2008, Pages 231-236

  Qasim, Atif ^a   Mehta, Nehal N ^a   Tadesse, Mahlet G ^b   Wolfe, Megan L ^a   Rhodes, Thomas ^c   Girman, Cynthia ^c   Reilly, Muredach P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

adiponectin; atherosclerosis; coronary artery calcification; inflammation; leptin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGED; ARTERY CALCIFICATION; ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; GENDER; HOMEOSTASIS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR;

ADIPOKINES; ADIPOSITY; ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCINOSIS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; LEPTIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS;

EID: 46249084673     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.04.016     Document Type: Article

References (48)

1. Mohamed-Ali V., Pinkney J.H., and Coppack S.W. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 22 (1998) 1145-1158
2. Koerner A., Kratzsch J., and Kiess W. Adipocytokines: leptin-the classical, resistin-the controversical, adiponectin-the promising, and more to come. Best Pract Res Clin Endocrinol Metab 19 (2005) 525-546
3. Takemura Y., Ouchi N., Shibata R., et al. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J Clin Invest 117 (2007) 375-386
4. Behre C.J. Adiponectin, obesity and atherosclerosis. Scand J Clin Lab Invest 67 (2007) 449-458
5. Kumada M., Kihara S., Sumitsuji S., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23 (2003) 85-89
6. Pilz S., Maerz W., Weihrauch G., et al. Adiponectin serum concentrations in men with coronary artery disease: the LUdwigshafen RIsk and Cardiovascular Health (LURIC) study. Clin Chim Acta 364 (2006) 251-255
7. Schulze M.B., Shai I., Rimm E.B., Li T., Rifai N., and Hu F.B. Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes 54 (2005) 534-539
8. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., and Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291 (2004) 1730-1737
9. Lawlor D.A., Davey Smith G., Ebrahim S., Thompson C., and Sattar N. Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. J Clin Endocrinol Metab 90 (2005) 5677-5683
10. Lindsay R.S., Resnick H.E., Zhu J., et al. Adiponectin and coronary heart disease: the Strong Heart Study. Arterioscler Thromb Vasc Biol 25 (2005) e15-e16
11. Hamann A., and Matthaei S. Regulation of energy balance by leptin. Exp Clin Endocrinol Diabetes 104 (1996) 293-300
12. Segal K.R., Landt M., and Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 45 (1996) 988-991
13. Chu N.F., Spiegelman D., Rifai N., Hotamisligil G.S., and Rimm E.B. Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men. Int J Obes Relat Metab Disord 24 (2000) 1085-1092
14. Haynes W.G. Role of leptin in obesity-related hypertension. Exp Physiol 90 (2005) 683-688
15. Wallace A.M., McMahon A.D., Packard C.J., et al. Plasma leptin and the risk of cardiovascular disease in the West Of Scotland Coronary Prevention Study (WOSCOPS). Circulation 104 (2001) 3052-3056
16. Reilly M.P., Iqbal N., Schutta M., et al. Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. J Clin Endocrinol Metab 89 (2004) 3872-3878
17. Soderberg S., Ahren B., Jansson J.H., et al. Leptin is associated with increased risk of myocardial infarction. J Intern Med 246 (1999) 409-418
18. Couillard C., Lamarche B., Mauriege P., et al. Leptinemia is not a risk factor for ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Diabetes Care 21 (1998) 782-786
19. Reilly M.P., Lehrke M., Wolfe M.L., Rohatgi A., Lazar M.A., and Rader D.J. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111 (2005) 932-939
20. Reilly M.P., Rohatgi A., McMahon K., et al. Plasma cytokines, metabolic syndrome, and atherosclerosis in humans. J Invest Med 55 (2007) 26-35
21. Reilly M.P., Wolfe M.L., Localio A.R., and Rader D.J. C-reactive protein and coronary artery calcification: the Study of Inherited Risk of Coronary Atherosclerosis (SIRCA). Arterioscler Thromb Vasc Biol 23 (2003) 1851-1856
22. Reilly M.P., Wolfe M.L., Rhodes T., Girman C., Mehta N., and Rader D.J. Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis. Circulation 110 (2004) 803-809
23. Reilly M.P., Wolfe M.L., Localio A.R., and Rader D.J. Coronary artery calcification and cardiovascular risk factors: impact of the analytic approach. Atherosclerosis 173 (2004) 69-78
24. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
25. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112 (2005) 2735-2752
26. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
27. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte Jr. M., and Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15 (1990) 827-832
28. Tobin J. Estimation of relationships for limited dependent variables. Econometrica 26 (1958) 24-36
29. UCLA Academic Technical Services. Stata Data Analysis Examples Tobit Analysis. Available at: http://www.ats.ucla.edu/stat/stata/dae/tobit.htm. Accessed April 25, 2008.
30. Enriori P.J., Evans A.E., Sinnayah P., and Cowley M.A. Leptin resistance and obesity. Obesity (Silver Spring) 14 Suppl 5 (2006) 254S-258S
31. Parhami F., Tintut Y., Ballard A., Fogelman A.M., and Demer L.L. Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res 88 (2001) 954-960
32. Stangl K., Cascorbi I., Laule M., et al. Elevated serum leptin in patients with coronary artery disease: no association with the Trp64Arg polymorphism of the beta3-adrenergic receptor. Int J Obes Relat Metab Disord 24 (2000) 369-375
33. Wolk R., Berger P., Lennon R.J., Brilakis E.S., Johnson B.D., and Somers V.K. Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am Coll Cardiol 44 (2004) 1819-1824
34. van den Beld A.W., Bots M.L., Janssen J.A., Pols H.A., Lamberts S.W., and Grobbee D.E. Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 157 (2003) 25-31
35. Ciccone M., Vettor R., Pannacciulli N., et al. Plasma leptin is independently associated with the intima-media thickness of the common carotid artery. Int J Obes Relat Metab Disord 25 (2001) 805-810
36. Iribarren C., Husson G., Go A.S., et al. Plasma leptin levels and coronary artery calcification in older adults. J Clin Endocrinol Metab 92 (2007) 729-732
37. Stefan N., and Stumvoll M. Adiponectin-its role in metabolism and beyond. Horm Metab Res 34 (2002) 469-474
38. Ouchi N., Kihara S., Arita Y., et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102 (2000) 1296-1301
39. Ouchi N., Kihara S., Arita Y., et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103 (2001) 1057-1063
40. Liang K.W., Sheu W.H., Lee W.L., et al. Decreased circulating protective adiponectin level is associated with angiographic coronary disease progression in patients with angina pectoris. Int J Cardiol (2007) Jul 23 [e-pub ahead of print]
41. Maahs D.M., Ogden L.G., Kinney G.L., et al. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation 111 (2005) 747-753
42. Sattar N., Wannamethee G., Sarwar N., et al. Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation 114 (2006) 623-629
43. Steffes M.W., Gross M.D., Lee D.H., Schreiner P.J., and Jacobs Jr. D.R. Adiponectin, visceral fat, oxidative stress, and early macrovascular disease: the Coronary Artery Risk Development in Young Adults Study. Obesity (Silver Spring) 14 (2006) 319-326
44. Pajvani U.B., Du X., Combs T.P., et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem 278 (2003) 9073-9085
45. Yamauchi T., Kamon J., Waki H., et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 278 (2003) 2461-2468
46. Bertoni A.G., Wong N.D., Shea S., et al. Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 30 (2007) 2951-2956
47. Mautner G.C., Mautner S.L., Froehlich J., et al. Coronary artery calcification: assessment with electron beam CT and histomorphometric correlation. Radiology 192 (1994) 619-623
48. Kondos G.T., Hoff J.A., Sevrukov A., et al. Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation 107 (2003) 2571-2576